Arena Pharmaceuticals Inc (ARNA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

6154 NANCY RIDGE DRIVE SAN DIEGO, CA 92121

Seeks to discover, develop and commercialize novel and improved orally available drugs. Focuses efforts across G protein-coupled receptor targets and compounds within four therapeutic areas: metabolic diseases, central nervous system disorders, cardiovascular diseases and inflammatory disorders.

Data based on most recent fiscal year report
Market Cap2.276 Billion Shares Outstanding50.11 Million Avg Volume602.054 Thousand
1-Yr BETA vs S&P TR0.817 Current Ratio15.4 Quick Ratio15.4
View SEC Filings from ARNA instead.

View recent insider trading info

Funds Holding ARNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

46.7 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

35.1 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STELZER LAURIE EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-16 2

SCHMIDT JOAN EVP, GENERAL COUNSEL & SEC

  • Officer
0 2020-03-15 3

DALLAS JAYSON DONALD ALEXANDER PRESIDENT AND CEO

  • Officer
  • Director
123,283 2020-03-10 1

MUNSHI AMIT PRESIDENT AND CEO

  • Officer
  • Director
0 2020-03-01 4

LIND KEVIN ROBERT EXECUTIVE VP AND CFO

  • Officer
0 2020-03-01 3

AURENTZ VINCENT EXECUTIVE VP AND CBO

  • Officer
0 2020-03-01 4

KLASSEN PRESTON EVP AND CMO

  • Officer
0 2020-03-01 2

LISICKI ROBERT EVP, CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-03-01 4

SPECTOR STEVEN W EVP, GENERAL COUNSEL & SEC

  • Officer
17,437 2020-02-27 4

JARRETT JENNIFER

0 2020-02-12 1

NEIL GARRY ARTHUR CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-03 1

SONI MANMEET SINGH CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-02 1

HOFFMAN ROBERT CFO & SVP, FINANCE

  • Officer
0 2019-12-19 0

WOODS RANDALL E PRESIDENT & CHIEF EXEC OFFICER

  • Officer
  • Director
0 2019-12-19 2

GALLAHUE KIERAN

  • Director
2,035 2019-12-18 1

NOVA TINA SUSAN

  • Director
0 2019-09-18 1

WHITE CHRISTINE ANNA

  • Director
15,000 2019-09-06 0

FETZER OLIVER

  • Director
4,179 2019-06-13 1

SCHNEIDER PHILLIP M

  • Director
0 2019-05-09 0

SHANAHAN WILLIAM R JR CHIEF MEDICAL OFFICER

0 2018-01-05 0

BICE SCOTT H

  • Director
0 2017-06-13 0

HIXSON HARRY F JR

  • Director
0 2016-06-13 0

BELCHER DONALD D

  • Director
0 2016-06-13 0

BIELASZ JENNIFER KATHLEEN VP, FINANCE AND ACCOUNTING

  • Officer
0 2016-03-02 0

BEHAN DOMINIC P EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
0 2016-03-02 0

AUDET CRAIG MICHAEL SVP, OPN & HEAD GLOB REG AFRS

  • Officer
0 2016-03-02 0

MEZZINO MAURICE JAMES SVP, CORPORATE DEVELOPMENT

  • Officer
0 2016-03-02 0

LIEF JACK

  • Director
0 2015-06-11 0

AJIT-SIMH K A SR. VP, QUALITY & REG COMPL

  • Officer
0 2011-03-15 0

LAFORCE JAMES

  • Director
0 2010-03-17 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

STELZER LAURIE - Officer EVP & CHIEF FINANCIAL OFFICER

2020-03-16 A 6,300 a 6,300 0.00 direct

STELZER LAURIE - Officer EVP & CHIEF FINANCIAL OFFICER

2020-03-16 A 132,000 a 132,000 0.00 direct

SCHMIDT JOAN - Officer EVP, GENERAL COUNSEL & SEC

2020-03-15 A 132,000 a 132,000 0.00 direct

SCHMIDT JOAN - Officer EVP, GENERAL COUNSEL & SEC

2020-03-15 A 6,300 a 6,300 0.00 direct

SCHMIDT JOAN - Officer EVP, GENERAL COUNSEL & SEC

2020-03-15 A 132,000 a 132,000 0.00 direct

LIND KEVIN ROBERT - Officer EXECUTIVE VP AND CFO

2020-03-01 A 70,000 a 70,000 0.00 direct

LISICKI ROBERT - Officer EVP, CHIEF COMMERCIAL OFFICER

2020-03-01 A 70,000 a 70,000 0.00 direct

AURENTZ VINCENT - Officer EXECUTIVE VP AND CBO

2020-03-01 A 70,000 a 70,000 0.00 direct

MUNSHI AMIT - Director - Officer PRESIDENT AND CEO

2020-03-01 A 270,000 a 270,000 0.00 direct

KLASSEN PRESTON - Officer EVP AND CMO

2020-03-01 A 70,000 a 70,000 0.00 direct

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-27 M 7,970 d 0 17,437.00 direct

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-27 M 7,970 $14.90 a 17,437 17,437.00 direct

MUNSHI AMIT - Director - Officer PRESIDENT AND CEO

2020-02-13 M 15,200 d 199,800 7,750.00 direct

LIND KEVIN ROBERT - Officer EXECUTIVE VP AND CFO

2020-02-13 M 2,000 d 128,000 3,457.00 direct

LIND KEVIN ROBERT - Officer EXECUTIVE VP AND CFO

2020-02-13 M 2,000 $35.60 a 7,957 3,457.00 direct

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-13 M 2,472 d 1,254 9,467.00 direct

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-13 M 2,472 $32.50 a 15,339 9,467.00 direct

MUNSHI AMIT - Director - Officer PRESIDENT AND CEO

2020-02-13 S 15,200 $55.00 d 7,750 7,750.00 direct yes

LIND KEVIN ROBERT - Officer EXECUTIVE VP AND CFO

2020-02-13 M 2,500 d 77,500 3,457.00 direct

LIND KEVIN ROBERT - Officer EXECUTIVE VP AND CFO

2020-02-13 M 2,500 $19.40 a 5,957 3,457.00 direct

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-13 S 10,836 $55.00 d 9,467 9,467.00 direct yes

MUNSHI AMIT - Director - Officer PRESIDENT AND CEO

2020-02-13 M 15,200 $14.60 a 22,950 7,750.00 direct

LIND KEVIN ROBERT - Officer EXECUTIVE VP AND CFO

2020-02-13 S 4,500 $55.00 d 3,457 3,457.00 direct yes

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-13 M 4,964 d 2,536 9,467.00 direct

SPECTOR STEVEN W - Officer EVP, GENERAL COUNSEL & SEC

2020-02-13 M 4,964 $37.20 a 20,303 9,467.00 direct

AURENTZ VINCENT - Officer EXECUTIVE VP AND CBO

2020-02-05 S 9,000 $50.00 d 0 0.00 direct yes

MUNSHI AMIT - Director - Officer PRESIDENT AND CEO

2020-02-05 S 7,129 $50.00 d 7,750 7,750.00 direct yes

Elevate your investments